Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (141-150 of 382) with videos related to

Pageof 39
Sort By:
Heart (British Cardiac Society)|December 15, 2015
Controlled release metoprolol for aortic regurgitation: a randomised clinical trialKaspar Broch, Stig Urheim, Mai Tone Lønnebakken, et al.
European Heart Journal|February 18, 2005
Soluble CD40 ligand in acute and chronic heart failureThor Ueland, Pål Aukrust, Arne Yndestad, et al.
Expert Opinion on Pharmacotherapy|October 13, 2005
Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisationPål Aukrust, Arne Yndestad, Camilla Smith, et al.
Clinical Transplantation|May 9, 2022
Iron homeostasis in heart transplant recipients randomized to ferric derisomaltose or placeboKristine V Brautaset Englund, Charlotte M Østby, Kaspar Broch, et al.
Plos One|April 7, 2021
Outcomes in asymptomatic, severe aortic stenosisAnette Borger Kvaslerud, Kenan Santic, Amjad Iqbal Hussain, et al.
American Heart Journal|September 1, 2014
Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes: the randomized controlled Asker and Bærum Cardiovascular Diabetes (ABCD) studyAnne Pernille Ofstad, Odd Erik Johansen, Lars Gullestad, et al.
Clinical Science (London, England : 1979)|February 8, 2011
Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failureThor Ueland, Christen P Dahl, Lars Gullestad, et al.
Open Heart|September 28, 2018
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarctionThor Ueland, Ola Kleveland, Annika E Michelsen, et al.
Transplantation|May 30, 2006
Decreased endomyocardial RANKL expression in transplant coronary artery diseaseThor Ueland, Lars Gullestad, Svein Simonsen, et al.
Journal of the American College of Cardiology|March 7, 2006
A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery diseaseTorbjørn Holm, Thor Ueland, Bente Halvorsen, et al.
Pageof 39

Showing results (141-150 of 382) with videos related to

Sort By:
Pageof 39
Heart (British Cardiac Society)|December 15, 2015
Controlled release metoprolol for aortic regurgitation: a randomised clinical trialKaspar Broch, Stig Urheim, Mai Tone Lønnebakken, et al.
European Heart Journal|February 18, 2005
Soluble CD40 ligand in acute and chronic heart failureThor Ueland, Pål Aukrust, Arne Yndestad, et al.
Expert Opinion on Pharmacotherapy|October 13, 2005
Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisationPål Aukrust, Arne Yndestad, Camilla Smith, et al.
Clinical Transplantation|May 9, 2022
Iron homeostasis in heart transplant recipients randomized to ferric derisomaltose or placeboKristine V Brautaset Englund, Charlotte M Østby, Kaspar Broch, et al.
Plos One|April 7, 2021
Outcomes in asymptomatic, severe aortic stenosisAnette Borger Kvaslerud, Kenan Santic, Amjad Iqbal Hussain, et al.
American Heart Journal|September 1, 2014
Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes: the randomized controlled Asker and Bærum Cardiovascular Diabetes (ABCD) studyAnne Pernille Ofstad, Odd Erik Johansen, Lars Gullestad, et al.
Clinical Science (London, England : 1979)|February 8, 2011
Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failureThor Ueland, Christen P Dahl, Lars Gullestad, et al.
Open Heart|September 28, 2018
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarctionThor Ueland, Ola Kleveland, Annika E Michelsen, et al.
Transplantation|May 30, 2006
Decreased endomyocardial RANKL expression in transplant coronary artery diseaseThor Ueland, Lars Gullestad, Svein Simonsen, et al.
Journal of the American College of Cardiology|March 7, 2006
A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery diseaseTorbjørn Holm, Thor Ueland, Bente Halvorsen, et al.
Pageof 39